Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Diadexus Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Apr 2016 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Diadexus Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

05 May 2016 Wright Reports 56 $75.00

ValuEngine Rating and Forecast Report for DDXS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

01 May 2016 ValuEngine, Inc. 11 $25.00

DIADEXUS INC (DDXS=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

30 Apr 2016 Pechala's Reports 2 $25.00

DDXS- Dropping Coverage

Dropping Coverage

22 Apr 2016 Feltl & Company 4 $12.00

diaDexus, Inc. (DDXSD) - Financial Analysis Review

diaDexus, Inc. (DDXSD) - Financial Analysis Review Summary diaDexus, Inc. (diaDexus) is a medical diagnostics company t...

04 Nov 2015 GlobalData 43 $125.00

DDXS- Q3 sees inline revenue, net loss better than expected – maintain HOLD

Q3 sees inline revenue, net loss better than expected – maintain HOLD

29 Oct 2015 Feltl & Company 7 $58.00

diaDexus, Inc. (DDXSD) - Financial Analysis Review

diaDexus, Inc. (DDXSD) - Financial Analysis Review Summary diaDexus, Inc. (diaDexus) is a medical diagnostics company t...

21 Sep 2015 GlobalData 43 $125.00

ValuEngine Industry Report for Medical Products(DDXS)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

26 Aug 2015 ValuEngine, Inc. 10 $49.00

DDXS- Q2 disappointing, near-term visibility lacking – reduce to HOLD

Q2 disappointing, near-term visibility lacking – reduce to HOLD

14 Aug 2015 Feltl & Company 9 $81.00